Haberkorn U - Search Results

1

Identification and evaluation of a new tumor cell-binding peptide, FROP-1.

Zitzmann S, Krämer S, Mier W, Hebling U, Altmann A, Rother A, Berndorff D, Eisenhut M, Haberkorn U. Zitzmann S, et al. Among authors: haberkorn u. J Nucl Med. 2007 Jun;48(6):965-72. doi: 10.2967/jnumed.106.036699. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504878 Free article.

2

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

Haberkorn U, Reinhardt M, Strauss LG, Oberdorfer F, Berger MR, Altmann A, Wallich R, Dimitrakopoulou A, van Kaick G. Haberkorn U, et al. J Nucl Med. 1992 Nov;33(11):1981-7. J Nucl Med. 1992. PMID: 1432159 Free article.

3

Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.

Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G. Haberkorn U, et al. J Nucl Med. 1991 Aug;32(8):1548-55. J Nucl Med. 1991. PMID: 1869977 Free article.

4

Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

Haberkorn U, Morr I, Oberdorfer F, Bellemann ME, Blatter J, Altmann A, Kahn B, van Kaick G. Haberkorn U, et al. J Nucl Med. 1994 Nov;35(11):1842-50. J Nucl Med. 1994. PMID: 7965167 Free article.

5

Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma.

Dimitrakopoulou A, Strauss LG, Clorius JH, Ostertag H, Schlag P, Heim M, Oberdorfer F, Helus F, Haberkorn U, van Kaick G. Dimitrakopoulou A, et al. Among authors: haberkorn u. J Nucl Med. 1993 Jul;34(7):1075-81. J Nucl Med. 1993. PMID: 8315481 Free article.

6

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.

Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, Reisser C, Doll J, Helus F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1993 Jan;34(1):12-7. J Nucl Med. 1993. PMID: 8418251 Free article.

7

Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.

Haberkorn U, Oberdorfer F, Gebert J, Morr I, Haack K, Weber K, Lindauer M, van Kaick G, Schackert HK. Haberkorn U, et al. J Nucl Med. 1996 Jan;37(1):87-94. J Nucl Med. 1996. PMID: 8544010 Free article.

8

Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.

Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Feb;38(2):287-94. J Nucl Med. 1997. PMID: 9025757 Free article.

9

Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.

Haberkorn U, Altmann A, Morr I, Germann C, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Jul;38(7):1048-54. J Nucl Med. 1997. PMID: 9225789 Free article.

10

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.

Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. Haberkorn U, et al. Nucl Med Biol. 1994 Aug;21(6):827-34. doi: 10.1016/0969-8051(94)90162-7. Nucl Med Biol. 1994. PMID: 9234332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters